Article info
Asthma
Original article
Defective IL-10 expression and in vitro steroid-induced IL-17A in paediatric severe therapy-resistant asthma
- Correspondence to Professor Catherine M Hawrylowicz, MRC & Asthma UK Centre for Allergic Mechanisms of Asthma, King's College London, Guy's Hospital, London SE1 9RT, UK; catherine.hawrylowicz{at}kcl.ac.uk
Citation
Defective IL-10 expression and in vitro steroid-induced IL-17A in paediatric severe therapy-resistant asthma
Publication history
- Received February 14, 2013
- Revised November 26, 2013
- Accepted November 28, 2013
- First published December 17, 2013.
Online issue publication
September 01, 2022
Article Versions
- Previous version (29 April 2016).
- You are viewing the most recent version of this article.
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Files in this Data Supplement:
- Data supplement 1 - Online supplement
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions